文献速递复苏、休克与脓毒症创伤与烧伤

冷藏非去白细胞全血随储存时间变化的止血潜力:血小板功能与凝血酶生成评估以确定最佳保存期

Hemostatic potential of cold-stored non-leukoreduced whole blood over time: An assessment of platelet function and thrombin generation for optimal shelf life.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论冷藏低滴度全血在储存7天和14天时血小板功能显著下降,但凝血启动稳定、凝血酶生成在7天后改善,研究支持将保存期限定为14天。

该研究从区域血库获取5单位新鲜低滴度O型非去白细胞全血,按现行临床储存指南在4°C下储存至21天,于0、7、14、21天体外检测细胞计数、快速血栓弹力图(r-TEG)、高岭土血栓弹力图(TEG)、多板阻抗聚集仪和校准自动凝血酶生成图(CAT)。与0天基线相比,血小板计数和血小板功能在7天和14天均急剧下降,r-TEG c(MA)、TEG-MA及多板花生四烯酸和二磷酸腺苷聚集均显示血小板功能恶化(均p<0.001)。凝血启动指标r-TEG ACT和TEG R-time在21天保存期内相似(p=0.058和p=0.620),CAT内源性凝血酶潜力稳定(p=0.162),但7天后凝血酶生成峰值升高、达峰时间缩短。研究支持冷藏低滴度全血现行保存期限为14天。

要点

  • 与0天基线相比,冷藏低滴度O型非去白细胞全血的血小板计数和血小板功能在7天和14天均急剧下降。
  • 血小板功能恶化经r-TEG c(MA)、TEG-MA及多板花生四烯酸和二磷酸腺苷聚集证实(均p<0.001)。
  • 凝血启动指标r-TEG ACT和TEG R-time在21天保存期内相似(p=0.058和p=0.620)。
  • CAT内源性凝血酶潜力在储存过程中稳定(p=0.162),但7天后凝血酶生成峰值升高、达峰时间缩短。
  • 研究支持冷藏低滴度全血现行保存期限为14天。

适用人群与场景

  • 新鲜低滴度O型非去白细胞全血,来自区域血库,用于初始失血性休克复苏。

研究设计与关键结果

  • 体外研究:5单位新鲜低滴度O型非去白细胞全血,在4°C下按现行临床储存指南储存至21天,于0、7、14、21天检测止血参数。
  • 与0天基线相比,血小板计数和血小板功能在7天和14天均急剧下降;r-TEG c(MA)、TEG-MA及多板花生四烯酸和二磷酸腺苷聚集均显示血小板功能恶化(均p<0.001)。
  • r-TEG ACT和TEG R-time在21天保存期内相似(p=0.058和p=0.620)。
  • CAT内源性凝血酶潜力在储存过程中稳定(p=0.162),但7天后凝血酶生成峰值升高、达峰时间缩短。

证据类型、等级与局限

  • 体外研究;单因素分析采用重复测量方差分析(STATA 12.1)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究支持冷藏低滴度全血的现行保存期限为14天。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Cold-stored low-titer whole blood (WB) is becoming increasingly used as the preferred product for initial hemorrhagic shock resuscitation. The purpose of this study was to identify whether the current 21-day shelf life is the optimal duration for storage of WB, maintaining hemostatic efficacy.

METHODS: Five units of fresh low-titer group O WB (non-leukoreduced) were acquired from our regional blood center. These units were stored at 4°C for up to 21 days as per current clinical storage guidelines in our emergency department. Hemostatic parameters were measured in vitro at 0 days, 7 days, 14 days, and 21 days. Assessments of hemostatic potential included cell count, rapid thrombelastography (r-TEG) and kaolin thrombelastography (TEG), multiplate impedance aggregometry, and calibrated automated thrombogram (CAT). Univariate analysis, including one-way analysis of variance with repeated measures, was performed (STATA 12.1).

RESULTS: Compared with baseline product (0 days), both platelet count and platelet function of WB showed sharp decreases at 7 days and again at 14 days. Platelet function deterioration was noted by r-TEG c (MA), TEG-MA, and multiplate arachidonic acid and adenosine diphosphate (all p < 0.001). With respect to clot initiation, r-TEG ACT and TEG R-time were similar over the 21-day shelf life (p = 0.058 and p = 0.620, respectively). Thrombin generation assessed by CAT demonstrated stable endogenous thrombin potential over the course of storage (p = 0.162), but increased peak thrombin generation and quicker time to peak generation after 7 days.

CONCLUSION: While the platelet function of WB degrades significantly at 7 days (and again at 14 days), clot initiation remains stable over time, and thrombin generation appears to be improved at 7 days. This study supports a current storage limit for cold-stored, low-titer WB of 14 days.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Assen S, Cardenas J, George M, et al. Hemostatic potential of cold-stored non-leukoreduced whole blood over time: An assessment of platelet function and thrombin generation for optimal shelf life. J Trauma Acute Care Surg. 2020. PMID: 32467473. doi:10.1097/TA.0000000000002799

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。